Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) is a publicly traded Healthcare sector company. As of October 22, 2026, KNSA trades at $80.40 with a market cap of $6.49B and a P/E ratio of 73.40. KNSA moved -4.24% today. Year to date, KNSA is +98.00%; over the trailing twelve months it is +113.31%. Its 52-week range spans $18.26 to $83.78. Analyst consensus is strong buy with an average price target of $96.57. Rallies surfaces KNSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KNSA moved -4.24% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $80.40 |
| Market Cap | $6.49B |
| P/E Ratio | 73.40 |
| EPS | $1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $83.78 |
| 52-Week Low | $18.26 |
| Volume | 716.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $840.85M |
| Net Income | $80.66M |
| Gross Margin | 89.82% |
7 analysts cover KNSA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $96.57.